Free tool
Healthcare stocks
We cover 157 companies in the Healthcare sector. The median market value in the group is $1.49B. Across the group, the median move over the past trading day is 0.00%. 94% of the 150 with a 200-day average trade above it. Price change over the past year runs from −19.2% to +270.2% across the middle 80 percent of the group, with a median of +39.6%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
157 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +2.99% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −18.65% |
| WATC34.SA | Waters Corporation | $36.35B | Large cap | +24.76% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | +2.68% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.89% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | −6.44% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| BHVN34.SA | BIOHAVEN LTDDRN | $694.68M | Small cap | −18.03% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| ICLR34.SA | ICON PLC DRN | $625.18M | Small cap | −14.33% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| KSI.TO | kneat.com, inc. | $452.27M | Small cap | +19.93% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| E2NO34.SA | Enovis Corporation | $387.44M | Small cap | −19.24% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| CGS.AX | Cogstate Limited | $376.22M | Small cap | +85.76% |
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −30.13% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| AVH.AX | AVITA Medical, Inc. | $324.65M | Small cap | +106.12% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| 6078.T | Value HR Co.,Ltd. | $273.03M | Small cap | +6.39% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| 4820.T | EM Systems Co., Ltd. | $262.55M | Small cap | −18.79% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% |
| ACB.TO | Aurora Cannabis Inc. | $252.71M | Small cap | −24.93% |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | $249.99M | Small cap | +90.38% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | $244.15M | Small cap | +14.45% |
| XLY.TO | Auxly Cannabis Group Inc. | $232.81M | Small cap | +1919.35% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| XI3.F | Bioceltix S.A. | $131.58M | Small cap | −28.67% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| A2ZT34.SA | Azenta, Inc. | $120.48M | Small cap | +50.80% |
| SDI.AX | SDI Ltd | $119.34M | Small cap | +60.41% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.